Concurrent PI3K and NF-κB activation drives B-cell lymphomagenesis

被引：4
作者：
Jin, H. Y. [1 ]
Lai, M. [1 ]
Shephard, J. [1 ]
Xiao, C. [1 ]
机构：
[1] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA
来源：
LEUKEMIA | 2016年 / 30卷 / 11期
关键词：
MICRORNA-17-SIMILAR-TO-92; PATHWAY; SIGNALS;
D O I：
10.1038/leu.2016.204
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：2267 / 2270
页数：5
相关论文
共 13 条
[1]   A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferation [J].
Hayashita, Y ;
Osada, H ;
Tatematsu, Y ;
Yamada, H ;
Yanagisawa, K ;
Tomida, S ;
Yatabe, Y ;
Kawahara, K ;
Sekido, Y ;
Takahashi, T .
CANCER RESEARCH, 2005, 65 (21) :9628-9632
[2]   A microRNA polycistron as a potential human oncogene [J].
He, L ;
Thomson, JM ;
Hemann, MT ;
Hernando-Monge, E ;
Mu, D ;
Goodson, S ;
Powers, S ;
Cordon-Cardo, C ;
Lowe, SW ;
Hannon, GJ ;
Hammond, SM .
NATURE, 2005, 435 (7043) :828-833
[3]   Cross-Talk between NFkB and the PI3-Kinase/AKT Pathway Can Be Targeted in Primary Effusion Lymphoma (PEL) Cell Lines for Efficient Apoptosis [J].
Hussain, Azhar R. ;
Ahmed, Saeeda O. ;
Ahmed, Maqbool ;
Khan, Omar S. ;
Al AbdulMohsen, Sally ;
Platanias, Leonidas C. ;
Al-Kuraya, Khawla S. ;
Uddin, Shahab .
PLOS ONE, 2012, 7 (06)
[4]   microRNA-17∼92 is a powerful cancer driver and a therapeutic target [J].
Jin, Hyun Yong ;
Lai, Maoyi ;
Xiao, Changchun .
CELL CYCLE, 2014, 13 (04) :495-496
[5]   MicroRNA-17∼92 plays a causative role in lymphomagenesis by coordinating multiple oncogenic pathways [J].
Jin, Hyun Yong ;
Oda, Hiroyo ;
Lai, Maoyi ;
Skalsky, Rebecca L. ;
Bethel, Kelly ;
Shepherd, Jovan ;
Kang, Seung Goo ;
Liu, Wen-Hsien ;
Sabouri-Ghomi, Mohsen ;
Cullen, Bryan R. ;
Rajewsky, Klaus ;
Xiao, Changchun .
EMBO JOURNAL, 2013, 32 (17) :2377-2391
[6]   Critical role of PI3K signaling for NF-κB-dependent survival in a subset of activated B-cell-like diffuse large B-cell lymphoma cells [J].
Kloo, Bernhard ;
Nagel, Daniel ;
Pfeifer, Matthias ;
Grau, Michael ;
Duewel, Michael ;
Vincendeau, Michelle ;
Doerken, Bernd ;
Lenz, Peter ;
Lenz, Georg ;
Krappmann, Daniel .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (01) :272-277
[7]   Targeting the phosphoinositide 3-kinase pathway in cancer [J].
Liu, Pixu ;
Cheng, Hailing ;
Roberts, Thomas M. ;
Zhao, Jean J. .
NATURE REVIEWS DRUG DISCOVERY, 2009, 8 (08) :627-644
[8]   Identification and characterization of a novel gene, C13orf25, as a target for 13q31-q32 amplification in malignant lymphoma [J].
Ota, A ;
Tagawa, H ;
Karnan, S ;
Tsuzuki, S ;
Karpas, A ;
Kira, S ;
Yoshida, Y ;
Seto, M .
CANCER RESEARCH, 2004, 64 (09) :3087-3095
[9]   Inhibition of the PI3K/AKT-NF-κB Pathway With Curcumin Enhanced Radiation-Induced Apoptosis in Human Burkitt's Lymphoma [J].
Qiao, Qiao ;
Jiang, Yuanjun ;
Li, Guang .
JOURNAL OF PHARMACOLOGICAL SCIENCES, 2013, 121 (04) :247-256
[10]   Canonical NF-κB activity, dispensable for B cell development, replaces BAFF-receptor signals and promotes B cell proliferation upon activation [J].
Sasaki, Yoshiteru ;
Derudder, Emmanuel ;
Hobeika, Elias ;
Pelanda, Roberta ;
Reth, Michael ;
Rajewsky, Klaus ;
Schmidt-Supprian, Marc .
IMMUNITY, 2006, 24 (06) :729-739
12